Innate Pharma Ownership | Who Owns Innate Pharma?
Innate Pharma Ownership Summary
Innate Pharma is owned by 0.05% institutional investors, 1.67% insiders, and 98.28% retail investors. Lion point capital, lp is the largest institutional shareholder, holding 0.09% of IPHA shares. Telescope Biotech Fund A FIL is the top mutual fund, with 0.25% of its assets in Innate Pharma shares.
IPHA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Innate Pharma | 0.05% | 1.67% | 98.28% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Lion point capital, lp | 81.15K | 0.09% | $103.87K |
| Morgan stanley | 43.52K | 0.05% | $55.71K |
| Jane street group | 43.37K | 0.05% | $55.51K |
| Citadel advisors | 23.53K | 0.03% | $45.64K |
| Millennium management | 10.06K | 0.01% | $12.88K |
| Rhumbline advisers | 4.73K | 0.01% | $6.06K |
| Ubs group | 861.00 | 0.00% | $1.10K |
| Gamma investing | 240.00 | 0.00% | $307.00 |
| Optiver b.v. | 101.00 | 0.00% | $197.00 |
| Caitong asset management | 2.00 | - | $3.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 81.15K | 0.62% | $103.87K |
| National bank of canada /fi/ | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Barclays | - | - | - |
| Optiver b.v. | 101.00 | - | $197.00 |
| Steward partners investment advisory | - | - | - |
| Jane street group | 43.37K | - | $55.51K |
| Gamma investing | 240.00 | - | $307.00 |
| Rhumbline advisers | 4.73K | - | $6.06K |
| Millennium management | 10.06K | - | $12.88K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Citadel advisors | 23.53K | - | 23.53K |
| Caitong asset management | 2.00 | - | 2.00 |
| Lion point capital, lp | 81.15K | 0.62% | - |
| Optiver b.v. | 101.00 | - | - |
| Farther finance advisors | 10.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Exchange traded concepts | - | - | -62.75K |
| Jane street group | 43.37K | - | -49.39K |
| Old mission capital | - | - | -28.43K |
| Millennium management | 10.06K | - | -10.24K |
| Morgan stanley | 43.52K | - | -2.87K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Citadel advisors | 23.53K | - | 23.53K | $45.64K |
| Caitong asset management | 2.00 | - | 2.00 | $3.00 |
Sold Out
| Holder | Change |
|---|---|
| Barclays | -1.00 |
| Tower research capital llc (trc) | -3.00 |
| Principal securities | -45.00 |
| Steward partners investment advisory | -200.00 |
| National bank of canada /fi/ | -450.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 6 | -45.45% | 49,212 | -82.19% | - | 51.42% | 1 | -83.33% | 4 | - |
| Dec 31, 2025 | 7 | -22.22% | 146,382 | 79.35% | - | 1876.05% | 2 | -33.33% | 4 | 100.00% |
| Sep 30, 2025 | 9 | 28.57% | 81,617 | 271.04% | - | 12997.79% | 3 | 50.00% | 2 | -33.33% |
| Jun 30, 2025 | 9 | -10.00% | 99,838 | -36.89% | - | 323.31% | 4 | -20.00% | 3 | 200.00% |
| Mar 31, 2025 | 1 | -88.89% | 15,326 | -88.89% | - | 64.33% | 1 | -50.00% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Telescope Biotech Fund A FIL | 236.48K | 0.25% | 102.43K |
| Range Cancer Therapeutics ETF | 62.75K | 0.07% | - |
| ActivePassive International Equity ETF | 37.49K | 0.05% | 132.00 |
IPHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools